Table 1 Data of the ten IPMN patients of which both non-invasive (dysplastic) and invasive (carcinoma) areas were found from their surgical specimens.
From: N-glycosylation in non-invasive and invasive intraductal papillary mucinous neoplasm
Patient number | Gender | Age | Operation year | Ca19-9 | IPMN maintype | IPMN Subtype | Dysplasia sample number | Grade of dysplasia | Cancer sample number | Cancer type | Neoadjuvant chemotherapy |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | male | 73 | 2002 | 329 | Main duct type | I | 1,1 | high grade | 1,2 | DAC | No |
3 | male | 75 | 2004 | 758 | Branch duct type | PB | 3,1 | low grade | 3,2 | DAC | No |
4 | female | 62 | 2006 | 36 | Branch duct type | PB | 4,1 | moderate | 4,2 | DAC | No |
5 | female | 65 | 2009 | 14 | Mixed type | PB | 5,1 | moderate | 5,2 | DAC | No |
6 | female | 64 | 2011 | 62 | Mixed type | PB | 6,1 | high grade | 6,2 | DAC | No |
7 | female | 79 | 2011 | 76 | Branch duct type | PB | 7,1 | high grade | 7,2 | DAC | Yes (gemcitabine) |
8 | female | 79 | 2011 | 74 | Mixed type | PB | 8,1 | low grade | 8,2 | DAC | No |
9 | male | 70 | 2011 | 2 | Branch duct type | PB | 9,1 | low grade | 9,2 | DAC | No |
10 | female | 76 | 2012 | 122 | Main duct type | I | 10,1 | high grade | 10,2 | DAC | No |
11 | male | 72 | 2014 | 89 | Mixed type | PB | 11,1 | moderate | 11,2 | DAC | No |
